base_Umsatzbase_Gewinnbase_KGVbase_KUVbase_EBITbase_Dividendebase_Aktienbase_Marktkapitalisierungbase_Schuldenbase_Verbindlichkeitenbase_Eigenkapitalbase_AAQSbase_Mitarbeiterbase_ROEbase_ROAbase_ROCE
Cassava Sciences base_Aktie

Cassava Sciences base_Gewinn 2025

Cassava Sciences base_Gewinn

−25,99 number_format_mio USD

components_StockPageHeader__3

SAVA

components_StockPageHeader__4

US14817C1071

components_StockPageHeader__5

A2PGL8

pages_kennzahlen_[key]_[isin]__21

pages_kennzahlen_[key]_[isin]__70

components_DataTable__24components_DataTable__5
2028e-
2027e425,30
2026e4,73
2025e−25,99
2024−24,34
2023−97,22
2022−76,25
2021−32,39
2020−6,33
2019−4,63
2018−6,56
2017−11,91
2016−14,85
2015−14,15
2014−12,39
201331,54
2012−3,45
2011−2,61
2010−12,02
2009−3,47
200815,35
200720,31
20066,19
2005−30,67

components_charts_RevenueChart_0

  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_RevenueChart_8
components_charts_RevenueChart_10
components_charts_RevenueChart_9
components_charts_RevenueChart_13

Cassava Sciences components_charts_RevenueChart_15

components_charts_RevenueChart_14Cassava Sciences components_charts_RevenueChart_8Cassava Sciences components_charts_RevenueChart_10Cassava Sciences components_charts_RevenueChart_9
2028e0 undefined−3,47 number_format_mio undefined0 undefined
2027e0 undefined−4,08 number_format_mio undefined425,30 number_format_mio undefined
2026e0 undefined−4,39 number_format_mio undefined4,73 number_format_mio undefined
2025e0 undefined−36,41 number_format_mio undefined−25,99 number_format_mio undefined
20240 undefined−141,45 number_format_mio undefined−24,34 number_format_mio undefined
20230 undefined−105,96 number_format_mio undefined−97,22 number_format_mio undefined
20220 undefined−80,02 number_format_mio undefined−76,25 number_format_mio undefined
20210 undefined−32,87 number_format_mio undefined−32,39 number_format_mio undefined
20200 undefined−6,80 number_format_mio undefined−6,33 number_format_mio undefined
20190 undefined−4,96 number_format_mio undefined−4,63 number_format_mio undefined
20180 undefined−6,66 number_format_mio undefined−6,56 number_format_mio undefined
20170 undefined−11,95 number_format_mio undefined−11,91 number_format_mio undefined
20160 undefined−14,96 number_format_mio undefined−14,85 number_format_mio undefined
20150 undefined−14,20 number_format_mio undefined−14,15 number_format_mio undefined
20140 undefined−12,43 number_format_mio undefined−12,39 number_format_mio undefined
201341,12 number_format_mio undefined31,37 number_format_mio undefined31,54 number_format_mio undefined
201210,89 number_format_mio undefined−3,90 number_format_mio undefined−3,45 number_format_mio undefined
201111,48 number_format_mio undefined−3,51 number_format_mio undefined−2,61 number_format_mio undefined
201016,81 number_format_mio undefined−13,70 number_format_mio undefined−12,02 number_format_mio undefined
200920,56 number_format_mio undefined−6,75 number_format_mio undefined−3,47 number_format_mio undefined
200863,73 number_format_mio undefined8,71 number_format_mio undefined15,35 number_format_mio undefined
200765,98 number_format_mio undefined10,17 number_format_mio undefined20,31 number_format_mio undefined
200653,92 number_format_mio undefined−550 000,00 undefined6,19 number_format_mio undefined
20055,08 number_format_mio undefined−32,72 number_format_mio undefined−30,67 number_format_mio undefined

components_charts_MarginsChart_0

components_charts_MarginsChart_18

  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_MarginsChart_15
components_charts_MarginsChart_17
components_charts_MarginsChart_16
components_charts_MarginsChart_19

Cassava Sciences components_charts_MarginsChart_21

Cassava Sciences components_charts_MarginsChart_15Cassava Sciences components_charts_MarginsChart_16Cassava Sciences components_charts_MarginsChart_17Cassava Sciences components_charts_MarginsChart_16
2028e0 %0 %0 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
20240 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %76,29 %76,70 %
20120 %−35,81 %−31,68 %
20110 %−30,57 %−22,74 %
20100 %−81,50 %−71,51 %
20090 %−32,83 %−16,88 %
20080 %13,67 %24,09 %
20070 %15,41 %30,78 %
20060 %−1,02 %11,48 %
20050 %−644,09 %−603,74 %

Cassava Sciences Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

Cassava Sciences Inc. is a biotechnology company founded in 1998. Its headquarters is in Austin, Texas. The company aims to research the inflammatory causes of neurodegenerative diseases, such as Alzheimer's, and develop new treatment options and medications. Cassava Sciences' business model is based on the development and commercialization of innovative therapies through research, clinical trials, and partnerships with other companies. The company focuses on developing treatment options for Alzheimer's disease. Cassava Sciences consists of various divisions that work closely together. One focus of the company is researching and developing new medications for the treatment of Alzheimer's. The company collaborates closely with scientists to develop new treatment options. Another important aspect of Cassava Sciences is conducting clinical trials to test the effectiveness and safety of the developed medications. The company collaborates with globally renowned research institutions. One of Cassava Sciences' products is the medication PTI-125, which was developed for the treatment of Alzheimer's. The medication aims to target the inflammatory causes of the disease and slow down its progression. PTI-125 is currently in Phase IIb of clinical testing and shows promising results. In recent years, Cassava Sciences has formed several partnerships with other companies to advance research and development of new treatment options. For example, the company collaborates with Pfizer and AbbVie. The history of Cassava Sciences is marked by intensive research activity and the goal of improving the quality of life for people with Alzheimer's disease. The company's research findings have been presented at scientific conferences and received significant media attention. In summary, Cassava Sciences is an innovative biotechnology company focused on researching and developing treatment options for Alzheimer's. In addition to developing new medications, the company also conducts clinical trials and collaborates with other companies to advance research. Cassava Sciences sees itself as a pioneer in the field of Alzheimer's therapy and aims to significantly improve the quality of life for people with this condition. Cassava Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_kennzahlen_[key]_[isin]__85

pages_kennzahlen_[key]_[isin]__72

pages_dividenden_[isin]_index__2

components_kpi_EarningFaqs_0

components_kpi_EarningFaqs_1

components_kpi_EarningFaqs_2

components_kpi_EarningFaqs_3

components_kpi_EarningFaqs_4

components_kpi_EarningFaqs_5

components_kpi_EarningFaqs_6

components_kpi_EarningFaqs_7

components_kpi_EarningFaqs_8

components_kpi_EarningFaqs_9

components_kpi_EarningFaqs_10

components_kpi_EarningFaqs_11

components_kpi_EarningFaqs_12

components_kpi_EarningFaqs_13

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Cassava Sciences kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

components_kpi_Savingsplan_0

components_kpi_Savingsplan_3

Andere Kennzahlen von Cassava Sciences

components_SimilarSitesList_0